Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues

Biomedical Reports
Xiaolong LinHuijun Hu

Abstract

The hepatokine fibroblast growth factor 21 (FGF21) is a novel polypeptide ligand, which is involved in glucose and lipid metabolism, and contributes significantly to lowering body weight and enhancing insulin sensitivity. A large number of pre-clinical and clinical results demonstrate that FGF21 is a potential drug target for treating obesity and type 2 diabetes mellitus. In the present review, the tissue specific actions and molecular mechanisms of FGF21 are discussed with a focus on the liver, adipose tissue and nervous system, as well as investigating the outcomes of clinical trials of FGF21, with the aim of interpreting and delineating the complexity physiology of FGF21.

References

Jun 20, 2000·Biochimica Et Biophysica Acta·T NishimuraN Itoh
May 4, 2004·American Journal of Human Genetics·Joelle M van der WaltEden R Martin
Sep 11, 2004·Biochemical and Biophysical Research Communications·Hidehisa YamagataIkuko Kondo
Oct 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·S J EvansH Akil
Nov 25, 2004·Diabetes·Louise HutleyJohannes Prins
May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt
Oct 26, 2006·Journal of Cellular Physiology·Julie S MoyersAlexei Kharitonenkov
Oct 28, 2006·Endocrinology·Alexei KharitonenkovGarret J Etgen
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yasushi OgawaMakoto Kuro-o
Jul 3, 2007·Biochemical and Biophysical Research Communications·Thomas LundåsenMats Rudling
Oct 11, 2007·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·W-W ChenG Boden
Nov 13, 2007·Peptides·Hung HsuchouAbba J Kastin
Dec 8, 2007·Journal of Cellular Physiology·Alexei KharitonenkovArmen B Shanafelt
Aug 9, 2008·Endocrinology·Tamer CoskunAlexei Kharitonenkov
Jan 1, 2009·Journal of Cellular Physiology·Radmila MicanovicAlexei Kharitonenkov
Jun 18, 2009·The Journal of Clinical Endocrinology and Metabolism·Constantinos ChristodoulidesFredrik Karpe
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Matthew J PotthoffShawn C Burgess
Aug 8, 2009·FEBS Letters·Katsumi IizukaYukio Horikawa
Aug 12, 2009·Gastroenterology·Charis L JohnsonChristopher L Pin
Aug 27, 2009·American Journal of Physiology. Endocrinology and Metabolism·Jing XuMurielle M Véniant
Oct 13, 2009·Endocrinology·Michael K BadmanEleftheria Maratos-Flier
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jennifer L EstallBruce M Spiegelman
Mar 25, 2010·The Journal of Biological Chemistry·Yongjun WangThomas P Burris
Apr 29, 2010·American Journal of Physiology. Endocrinology and Metabolism·Knut MaiJoachim Spranger
May 11, 2010·Gastroenterology·Jody DushayEleftheria Maratos-Flier
Jul 27, 2010·Human Molecular Genetics·Henna TyynismaaAnu Suomalainen
Jul 30, 2010·Molecular Endocrinology·Klementina Fon TacerSteven A Kliewer
Aug 5, 2010·Diabetes·Ffolliott M FisherEleftheria Maratos-Flier
Feb 15, 2011·The Journal of Biological Chemistry·Elayne HondaresFrancesc Villarroya
Mar 5, 2011·Molecular Medicine·Dionysios V ChartoumpekisAthanasios G Papavassiliou
Jun 30, 2011·Endocrinology·Ffolliott M FisherEleftheria Maratos-Flier

❮ Previous
Next ❯

Citations

Nov 22, 2018·Journal of Cachexia, Sarcopenia and Muscle·Qing ZhangYann-Gaël Gangloff
Feb 9, 2019·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Catherine ChaumontetPatrick C Even
Feb 27, 2020·Expert Opinion on Emerging Drugs·Juan P TrivellaAndres F Carrion
Dec 7, 2017·Current Medicinal Chemistry·Marta Olivera-Santa CatalinaJose J Lopez
Mar 31, 2019·Journal of Physiology and Biochemistry·Katarzyna DolegowskaBarbara Dolegowska
Apr 26, 2020·Scientific Reports·Ayelén Melisa BlancoSuraj Unniappan
Mar 12, 2020·Frontiers in Cardiovascular Medicine·Alan Chait, Laura J den Hartigh
May 1, 2020·Scientific Reports·Min PiL Darryl Quarles
May 21, 2019·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Michaela KeuperHarald Staiger
Jan 19, 2019·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Deborah AmosNalini Santanam
Mar 20, 2021·Médecine sciences : M/S·Guillaume BourdonPierre Henri Ducluzeau
May 6, 2021·Nature Reviews. Endocrinology·Leigh PerreaultJulio Rosenstock
Nov 5, 2021·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kota YanoYoshito Itoh

❮ Previous
Next ❯

Methods Mentioned

BETA
gene knockout
genetic modification

Related Concepts

Related Feeds

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.